0.3600 USD
-0.0100
2.70%
At close Dec 20, 4:00 PM EST
After hours
0.3600
+0.0000
0.00%
1 day
-2.70%
5 days
-10.00%
1 month
-20.56%
3 months
-22.58%
6 months
-42.86%
Year to date
-63.36%
1 year
-45.45%
5 years
-99.73%
10 years
-99.86%
 

About: cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD and hempMD. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD bath bombs, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.

Employees: 42

0
Funds holding %
of 6,809 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

47% more capital invested

Capital invested by funds: $50.2K [Q2] → $73.5K (+$23.3K) [Q3]

1.74% more ownership

Funds ownership: 2.21% [Q2] → 3.96% (+1.74%) [Q3]

0% more funds holding

Funds holding: 19 [Q2] → 19 (+0) [Q3]

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

40% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 5

Research analyst outlook

We haven’t received any recent analyst ratings for YCBD.

Financial journalist opinion

Based on 4 articles about YCBD published over the past 30 days

Neutral
Newsfile Corp
2 days ago
cbdMD Generates $19.1 Million in Year Over Year Reduction in Net Loss Improvement
Finishes the year with a stronger cash position. Charlotte, North Carolina--(Newsfile Corp. - December 18, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, along with its new functional mushroom brand ATRx Labs today announced our financial results for the full fiscal year ended September 30, 2024.
cbdMD Generates $19.1 Million in Year Over Year Reduction in Net Loss Improvement
Neutral
Newsfile Corp
3 days ago
cbdMD, Inc. to Host Conference Call to Discuss September 30, 2024 Fourth Quarter and Fiscal Year 2024 Results
Charlotte, North Carolina--(Newsfile Corp. - December 18, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Wednesday, December 18, 2024, to discuss the company's September 30, 2024 fourth quarter and fiscal year 2024 financial results and business progress.
cbdMD, Inc. to Host Conference Call to Discuss September 30, 2024 Fourth Quarter and Fiscal Year 2024 Results
Neutral
Newsfile Corp
3 days ago
cbdMD, Inc. Reschedules Earnings Release and Conference Call
Charlotte, North Carolina--(Newsfile Corp. - December 17, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), today announced that it has postponed the release of its financial results and conference call related to the fourth quarter and fiscal year ended September 30, 2024, which had previously been scheduled for December 17, 2024. cbdMD currently expects to issue its fourth quarter and fiscal year 2024 financial results after market close on Wednesday, December 18, 2024.
cbdMD, Inc. Reschedules Earnings Release and Conference Call
Neutral
Newsfile Corp
1 week ago
cbdMD, Inc. To Host Conference Call to Discuss September 30, 2024 Fourth Quarter and Fiscal Year 2024 Results
Charlotte, North Carolina--(Newsfile Corp. - December 12, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA) one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Tuesday, December 17, 2024, to discuss the company's September 30, 2024 fourth quarter and fiscal year 2024 financial results and business progress.
cbdMD, Inc. To Host Conference Call to Discuss September 30, 2024 Fourth Quarter and Fiscal Year 2024 Results
Neutral
Newsfile Corp
1 month ago
cbdMD Launches Herbal Oasis Social Tonics, Hemp-Derived THC Seltzers
Charlotte, North Carolina--(Newsfile Corp. - November 14, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBD-PA) a trusted leader in the wellness and cannabinoid industry, is excited to announce the launch of Herbal Oasis Social Tonics—a carefully crafted low-calorie, hemp derived THC seltzer line designed to elevate social occasions with a blend of premium cannabinoids and adaptogenic mushrooms. Available in four delicious flavors—Lemon Lift, Tropical Twist, Mango Bliss, and Berry Fusion—Herbal Oasis is designed to deliver an experience that enhances social connection and well-being, offering an alternative to traditional alcoholic drinks.
cbdMD Launches Herbal Oasis Social Tonics, Hemp-Derived THC Seltzers
Neutral
Newsfile Corp
3 months ago
cbdMD, Inc. Announces Acceptance of Compliance Plan by NYSE American
Charlotte, North Carolina--(Newsfile Corp. - August 26, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBD-PA), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, along with its functional mushroom brand ATRx Labs, today announced that it received notice from the NYSE American LLC that it had accepted the Company's plan to regain compliance with the NYSE American continued listing standards and granted a plan period through December 5, 2025. As previously disclosed on June 5, 2024, the Company received a letter from the NYSE American stating that the Company was not in compliance with the continued listing standards set forth in Sections 1003(a)(ii) of the NYSE American Company Guide.
cbdMD, Inc. Announces Acceptance of Compliance Plan by NYSE American
Neutral
Seeking Alpha
4 months ago
cbdMD, Inc. (YCBD) Q3 2024 Earnings Call Transcript
cbdMD, Inc. (NYSE:YCBD ) Q3 2024 Earnings Conference Call August 14, 2024 4:20 PM ET Company Participants Brad Whitford - Chief Accounting Officer Ronan Kennedy - Chief Executive Officer & Chief Financial Officer Conference Call Participants Thomas McGovern - Maxim Group Operator Good afternoon. Welcome to cbdMD's, Inc. June 30, 2024 Third Fiscal 2024 Quarter and Earnings Call and Update.
cbdMD, Inc. (YCBD) Q3 2024 Earnings Call Transcript
Neutral
Newsfile Corp
4 months ago
cbdMD Delivers on Sequential Revenue Growth and Positive Net Income for Q3 2024
cbdMD Achieves Significant Reduction in Operating Loss as Operational Efficiencies Significantly Improve in Q3 2024 Charlotte, North Carolina--(Newsfile Corp. - August 14, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBD-PA) one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, along with its new functional mushroom brand ATRx Labs today announced our financial results for our third quarter of fiscal 2024 ending June 30, 2024. This quarter, cbdMD made significant strides in its strategic objectives.
cbdMD Delivers on Sequential Revenue Growth and Positive Net Income for Q3 2024
Neutral
Newsfile Corp
4 months ago
cbdMD, Inc. to Host Conference Call to Discuss Third Quarter of Fiscal 2024 Results
Charlotte, North Carolina--(Newsfile Corp. - August 5, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBD-PA), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Wednesday, August 14, 2024, to discuss the company's June 30, 2024 third quarter of fiscal 2024 financial results and business progress.
cbdMD, Inc. to Host Conference Call to Discuss Third Quarter of Fiscal 2024 Results
Neutral
Newsfile Corp
5 months ago
cbdMD Announces Publication of Human Clinical Trial Data
Charlotte, North Carolina--(Newsfile Corp. - June 27, 2024) -  cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBD-PA) (the "Company"), one of the nation's leading providers of premium cannabidiol (CBD) products, today announced the publication of the Company's human clinical trial data demonstrating the benefits of its proprietary Broad Spectrum CBD blend. The data was published in the Journal of the International Society of Sports Nutrition.
cbdMD Announces Publication of Human Clinical Trial Data
Charts implemented using Lightweight Charts™